If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB.p Marsh Regulatory News (BPM)

Share Price Information for B.p Marsh (BPM)

Share Price is delayed by 15 minutes
Get Live Data
689.00    0.00 (0.00%)
Bid:
684.00
Ask:
694.00
Spread: 10.00 (1.462%)
Market Cap: £242.80m
BPM Live PriceLast checked at - London Stock Exchange

Intraday B.p Marsh Share Chart

Further Investment

17 Jun 2015 15:41

RNS Number : 4752Q
B.P. Marsh & Partners PLC
17 June 2015
 

Date: 17th June 2015

On behalf of: B.P. Marsh & Partners Plc

Immediate release

B.P. Marsh & Partners Plc

("B.P. Marsh", "the Company" or "the Group")

Further Investment in Nexus Underwriting Management Limited

 

B.P. Marsh & Partners Plc (AIM: BPM), the niche venture capital provider to early stage financial services businesses, is pleased to announce that it has subscribed for a further investment in Nexus Underwriting Management Limited ("Nexus"), an independent specialty Managing General Agency ("MGA"), for a total consideration of £1,554,000. B.P. Marsh has acquired new Preferred Ordinary shares representing 5% of the enlarged share capital of Nexus, and the acquisition takes B.P. Marsh's shareholding in Nexus to 9.8% for an aggregate consideration of £3,108,000.

 

Nexus is one of the largest independent specialty MGAs in the London Market with a forecast Premium Income in excess of £65m for 2015. It operates across the major insurance sectors, including Financial Lines, Trade Credit & Political Risk, Accident & Health and various other niche areas of insurance, where its specialist skills come to the fore.

 

The Group acquired an initial shareholding in Nexus of 5% in August 2014, with the intention to increase its shareholding over time, in support of Nexus's growth aspirations. As such the Group has provided this finance in connection with a proposed acquisition by Nexus, which will add significantly to its Gross Written Insurance Premium Income, and also its profitability and its geographical footprint across Europe. The Company will announce further details of this transaction in due course.

 

Nexus Group CEO Colin Thompson stated "We are delighted to conclude this funding with B.P. Marsh as it provides further access to capital on agreeable terms. The capital will not only be used to conclude a specific transaction but also underpins our wider M&A agenda which will take Nexus into new product lines and new geographic areas, in order to pursue our growth strategy."

 

Daniel Topping, the Company's nominee director on the Board of Nexus commented "I am pleased to conclude this round of funding which will allow Nexus to pursue their ongoing growth strategy and, we anticipate, will continue to deliver significant underlying growth to the Group's Net Asset Value. This investment underlines B.P. Marsh's strategy of providing growth finance to specialist financial intermediaries, to which we have unrivalled access through our niche area of operation."

 

 

For further information:

 

B.P. Marsh & Partners Plc www.bpmarsh.co.uk

Brian Marsh OBE +44 (0)20 7233 3112

 

Nominated Adviser & Broker

Panmure Gordon

Fred Walsh / Charles Leigh-Pemberton / Atholl Tweedie +44 (0)20 7886 2500

 

Notes to Editors:

 

About B.P. Marsh & Partners Plc

 

B.P. Marsh's current portfolio contains thirteen companies. More detailed descriptions of the portfolio can be found at www.bpmarsh.co.uk.

Since formation over 20 years ago, the Company has assembled a management team with considerable experience both in the financial services sector and in managing private equity investments. Many of the directors have worked with each other in previous roles, and all have worked with each other for at least five years.

Prior to Brian Marsh's involvement in the Company, he spent many years in insurance broking and underwriting in Lloyd's as well as the London and overseas market. He has over 30 years' experience in building, buying and selling financial services businesses, particularly in the insurance sector.

Jonathan Newman is a Chartered Management Accountant and is the Group Director of Finance and has over 17 years' experience in the financial services industry. Jonathan advises investee companies and has a number of non-executive appointments over three investee companies and evaluates new investment opportunities.

Daniel Topping is a Member of the Chartered Institute of Securities and Investment (MCSI) and an Associate of the Institute of Chartered Secretaries and Administrators (ACIS), having graduated from the University of Durham in 2005. Dan joined B.P. Marsh in February 2007 having started his career at an accountancy firm. In 2011 he was appointed as a director of B.P. Marsh and currently has a number of non-executive appointments over seven investee companies and evaluates new investment opportunities.

Camilla Kenyon was appointed as Head of Investor Relations at B.P. Marsh in February 2009, having four years' prior experience with the Company. Camilla has a number of non-executive appointments over two investee companies, is Chair of the New Business Committee and is a Member of the Investor Relations Society.

Alice Foulk joined B.P. Marsh in September 2011 having started her career at a leading Life Assurance company. In 2014 she took over as Executive Assistant to the Chairman, running the Chairman's Office and in December 2014 was appointed interim Head of New Business.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRGGUBWQUPAGCM
Date   Source Headline
7th Oct 202511:15 amRNSNotice of HY Results and Investor Presentation
30th Sep 20253:52 pmRNSNew Investment: Oneglobal Broking Holdings Limited
23rd Sep 20257:00 amRNSTrading Update
22nd Sep 20253:23 pmRNSNew Investment
12th Sep 20257:00 amRNSNew Investment: Supporting the Growth of XPT Group
29th Aug 20253:54 pmRNSNew Investment - Supporting the Growth of Pantheon
22nd Aug 20252:32 pmRNSDirector/PDMR Shareholding
14th Aug 20257:00 amRNSNew Investment- supporting the growth of XPT Group
11th Aug 202512:50 pmRNSHolding(s) in Company
11th Aug 202510:35 amRNSHolding(s) in Company
11th Aug 202510:35 amRNSHolding(s) in Company
7th Aug 202512:44 pmRNSHolding(s) in Company
7th Aug 20257:05 amRNSBuyback Results, Transaction in Own Shares and TVR
7th Aug 20257:00 amRNSResult of Secondary Placing
6th Aug 20254:51 pmRNSProposed Buyback
6th Aug 20254:40 pmRNSPROPOSED SECONDARY PLACING
4th Aug 20257:00 amRNSPurchase of Own Shares and Total Voting Rights
31st Jul 20258:05 amRNSPurchase of Own Shares and Total Voting Rights
17th Jul 202512:31 pmRNSResult of AGM
16th Jul 20257:00 amRNSPurchase of Own Shares and Total Voting Rights
15th Jul 20257:00 amRNSPurchase of Own Shares and Total Voting Rights
14th Jul 20252:10 pmRNSHolding(s) in Company
14th Jul 20257:00 amRNSPurchase of Own Shares and Total Voting Rights
11th Jul 20257:00 amRNSPurchase of Own Shares and Total Voting Rights
3rd Jul 20254:30 pmRNSHolding(s) in Company
1st Jul 20257:00 amRNSPurchase of Own Shares and Total Voting Rights
30th Jun 20257:00 amRNSPurchase of Own Shares
30th Jun 20257:00 amRNSFollow-on equity purchase in and loan to Pantheon
24th Jun 20251:15 pmRNSNotice of AGM - correction
24th Jun 202511:39 amRNSNotice of AGM
20th Jun 202510:13 amRNSPurchase of Own Shares and Total Voting Rights
17th Jun 20257:00 amRNSNew Investment – Cameron Specialty HoldCo Limited
12th Jun 202512:30 pmRNSDirector/PDMR Shareholding
11th Jun 20254:18 pmRNSDirector/PDMR Shareholding
11th Jun 20253:33 pmRNSHolding(s) in Company
10th Jun 20254:45 pmRNSDirector/PDMR Shareholding
10th Jun 202511:30 amRNSFinal Dividend Declaration
10th Jun 20257:00 amRNSFinal Results for the Year to 31 January 2025
5th Jun 202511:15 amRNSSale of Interest in Sterling Insurance Pty Ltd
4th Jun 20252:45 pmRNSNew Investment - Amiga Speciality Holdings Limited
4th Jun 202512:23 pmRNSNotice of Annual Results and Investor Presentation
3rd Jun 202511:44 amRNSResult of Meeting
14th May 20255:34 pmRNSHolding(s) in Company
14th May 20254:53 pmRNSHolding(s) in Company
12th May 20253:17 pmRNSSecondary Share Sale
12th May 202512:15 pmRNSShare BuyBack, Notice of GM and Rule 9 Waiver
9th May 202512:49 pmRNSResult of Secondary Placing
8th May 20254:40 pmRNSProposed Secondary Placing
24th Apr 20259:59 amRNSDirector/PDMR Shareholding
23rd Apr 20257:00 amRNSNew Investment - iO Partners

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.